← Back to Photodynamic Therapy (PDT)

Is PDT Safe, and Who Should Avoid It?

A closer look at the real contraindications and rare risks of photodynamic therapy

Medically reviewed by Dr. Steven Q. Wang, MDLast reviewed

Bring a printable list of questions to your appointment, or share this page with someone who needs it.

Download printable checklist (PDF)

Introduction

Photodynamic therapy (PDT) has been used to treat actinic keratosis (AK) and other sun-damaged, precancerous skin for more than three decades, and its safety profile is well established: a 2019 consensus review commissioned by the British Association of Dermatologists concluded that topical PDT is generally well tolerated, with no documented evidence of cumulative toxicity or long-term photocarcinogenic risk from the treatment itself. That track record is reassuring, but it doesn't mean PDT is right for everyone.

Because PDT works by combining a photosensitizing agent with light exposure, its contraindications cluster around a specific theme: anything that makes the skin already abnormally sensitive to light, or that could make a phototoxic reaction dangerous rather than merely uncomfortable. This article goes through those contraindications and the rare risks of PDT in real clinical detail, so you know what your dermatologist is screening for and why.

Have Questions?

Ask questions and get clear, trusted answers — instantly.

Chat with the Navigator

Photosensitivity Disorders

The clearest contraindications to PDT are conditions that already make the skin abnormally reactive to light:

  • •Porphyria cutanea tarda and other porphyrias. These conditions involve a buildup of porphyrins — the same class of light-reactive molecules that PDT deliberately generates inside targeted cells using a photosensitizing agent. In someone who already has excess porphyrins circulating or accumulated in the skin, adding a photosensitizing agent and then exposing the skin to light risks an exaggerated, poorly controlled phototoxic reaction well beyond what PDT normally causes. For this reason, porphyria is considered an absolute contraindication to PDT.
  • •Lupus erythematosus, particularly cutaneous forms with a photosensitive component. Ultraviolet and visible light can trigger lupus skin flares in susceptible patients, so PDT's light-based mechanism raises a similar theoretical concern. This is usually treated as a relative rather than absolute contraindication — the decision depends on the specific lupus subtype, disease activity, and often input from the patient's rheumatologist.
  • •Other photodermatoses, such as polymorphic light eruption or solar urticaria, may also need individual evaluation, since they reflect a baseline abnormal light sensitivity that PDT's light-activation step could aggravate.

Photosensitizing Medications

A number of common medications and supplements can independently increase how strongly skin reacts to light, and combining them with PDT's photosensitizing agent may intensify the treatment reaction or extend how long the skin stays light-sensitive afterward. Your dermatologist will ask about your full medication list, including:

  • •Certain antibiotics — tetracyclines (such as doxycycline) and fluoroquinolones are well-known photosensitizers.
  • •Thiazide diuretics and some other blood pressure medications.
  • •Amiodarone, a heart-rhythm medication with a particularly strong and long-lasting photosensitizing effect.
  • •St. John's wort and certain other herbal supplements.

This doesn't automatically rule PDT out — it often just means the timing or dose is discussed, or the medication is temporarily paused if that's medically reasonable. Never stop a prescribed medication on your own; let your dermatologist coordinate with the prescribing physician.

Allergy, Pregnancy, and Practical Exclusions

  • •Known allergy to the photosensitizing agent. A prior allergic or significant contact reaction to ALA or MAL is an absolute contraindication to using that same agent again. True allergy is uncommon, but a 2019 consensus review flagged contact allergy to photosensitizer prodrugs as a real, if rare, adverse effect worth watching for — particularly in patients who have had multiple PDT courses to large areas over time.
  • •Pregnancy and breastfeeding. There isn't robust safety data on ALA or MAL in pregnant or breastfeeding patients, so PDT is generally deferred as a precaution rather than used on the assumption it's safe. If treatment can reasonably wait, most dermatologists will recommend waiting.
  • •Inability to comply with post-treatment light avoidance. After treatment, skin remains photosensitized for roughly 24–48 hours and needs to be shielded from direct sunlight and bright indoor light. Someone who can't realistically avoid sun exposure during that window — because of work, travel, or living circumstances — may need to reschedule or choose a different treatment.
  • •Very thick, deeply invasive, or ambiguous lesions. PDT penetrates a limited depth into the skin, so lesions that are unusually thick, hyperkeratotic, or that raise concern for invasive skin cancer rather than a straightforward AK may need a biopsy or a different treatment approach first.

Rare Risks, Discussed Honestly

Beyond the expected redness, swelling, and peeling that follow nearly every PDT session, a small number of less common effects are worth knowing about:

  • •Severe local reactions. Occasionally the treatment reaction is more intense than typical — pronounced blistering, crusting, or erosion — usually from a longer incubation time, a more potent light source, or unusually sun-damaged skin. This is uncomfortable but generally heals like the milder, more common reaction, just over a longer course.
  • •Scarring. True scarring after PDT is uncommon, since the treatment is designed to spare healthy tissue, but it can occur, particularly after a severe reaction, a secondary infection, or in someone prone to scarring.
  • •Pigment changes. Temporary lightening or darkening of treated skin can follow the healing process, more often in people with deeper skin tones (higher Fitzpatrick skin types); it usually fades over weeks to months but is occasionally longer-lasting.
  • •Rare allergic reaction to the photosensitizing agent itself, ranging from localized contact allergy to, very rarely, a more generalized reaction.

The consensus literature is reassuring on the bigger picture: aside from acute pain and these uncommon effects, there is no established evidence that PDT carries a cumulative or long-term cancer risk of its own — a relevant point given that PDT is used specifically to treat pre-cancerous skin.

How Dermatologists Screen Before Treatment

Before recommending PDT, a dermatologist will typically review your full medical history for a personal or family history of porphyria, ask about photosensitive conditions like lupus, take a complete medication and supplement list, ask about pregnancy or breastfeeding status when relevant, confirm you understand and can follow the post-treatment sun-avoidance window, and examine the lesions themselves to rule out anything needing a biopsy first. This screening is routine, not a sign that something is expected to go wrong — it's how PDT's strong overall safety record is maintained in practice.

What to Ask Your Doctor

Download printable checklist (PDF)
  • •Do any of my current medications or supplements increase my sensitivity to light?
  • •Should I be screened for porphyria or another photosensitivity disorder before treatment?
  • •Given my lupus (or other photosensitive condition), is PDT still a reasonable option for me?
  • •What should I realistically expect to be able to do — and avoid — in the 24–48 hours after treatment?
  • •What would a severe reaction look like, and when should I call the office instead of waiting it out?

Conclusion

PDT's decades-long track record makes it one of the more thoroughly vetted treatments for actinic keratosis, and for most people it is safe and well tolerated. That safety record depends on real screening: porphyria, significant photosensitive conditions like lupus, known allergy to the photosensitizing agent, certain medications, pregnancy or breastfeeding, and an inability to follow post-treatment sun avoidance are all reasons a dermatologist might recommend a different approach.

If any of these apply to you, it doesn't necessarily mean PDT is off the table permanently — bring it up directly, so your dermatologist can weigh your specific situation rather than you ruling yourself out (or in) on your own.

Sources

Clinical Guidelines & Peer-Reviewed Literature

  • Ibbotson SH, Wong TH, Morton CA, et al. Adverse effects of topical photodynamic therapy: a consensus review and approach to management. Br J Dermatol. 2019;180(4):715-729. PubMed
  • Eisen DB, Asgari MM, Bennett DD, et al. Guidelines of care for the management of actinic keratosis. J Am Acad Dermatol. 2021;85(4):e209-e233. PubMed

Patient Resources

Disclaimer: This page is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified dermatologist about your diagnosis and treatment plan.

Need More Information?

Chat with our AI guide for information about photodynamic therapy

Chat with the Navigator